Last reviewed · How we verify
Fluconazole Oral Product
Fluconazole Oral Product is a Small molecule drug developed by Radboud University Medical Center. It is currently in Phase 1 development.
At a glance
| Generic name | Fluconazole Oral Product |
|---|---|
| Sponsor | Radboud University Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Pyrexia
- Blood albumin decreased
- Blood sodium decreased
- Blood potassium decreased
- Hypokalaemia
- Anaemia
- Blood glucose increased
- Aspartate aminotransferase increased
- Haemoglobin decreased
- Hypomagnesaemia
- Vomiting
- Platelet count decreased
Key clinical trials
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation (PHASE2)
- Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies (PHASE1)
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (PHASE3)
- Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis (PHASE4)
- A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants (PHASE1)
- Study of Biomarker-Based Treatment of Acute Myeloid Leukemia (PHASE1, PHASE2)
- Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant (PHASE1, PHASE2)
- A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fluconazole Oral Product CI brief — competitive landscape report
- Fluconazole Oral Product updates RSS · CI watch RSS
- Radboud University Medical Center portfolio CI
Frequently asked questions about Fluconazole Oral Product
What is Fluconazole Oral Product?
Fluconazole Oral Product is a Small molecule drug developed by Radboud University Medical Center.
Who makes Fluconazole Oral Product?
Fluconazole Oral Product is developed by Radboud University Medical Center (see full Radboud University Medical Center pipeline at /company/radboud-university-medical-center).
What development phase is Fluconazole Oral Product in?
Fluconazole Oral Product is in Phase 1.
What are the side effects of Fluconazole Oral Product?
Common side effects of Fluconazole Oral Product include Pyrexia, Blood albumin decreased, Blood sodium decreased, Blood potassium decreased, Hypokalaemia, Anaemia.